Patents by Inventor Gabriela Gebrin Cezar

Gabriela Gebrin Cezar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Metabolic biomarkers of autism
    Patent number: 10330688
    Abstract: This invention provides methods and biomarkers for diagnosing autism by identifying cellular metabolites differentially produced in autistic patient samples versus non-autistic controls. Methods for identifying a unique profile of metabolites present or secreted in brain tissue, cerebrospinal fluid, plasma, or biofluids of autistic samples are described herein. The individual metabolites or a pattern of secreted metabolites provides metabolic signatures of autism, which can be used to provide a diagnosis thereof.
    Type: Grant
    Filed: December 7, 2016
    Date of Patent: June 25, 2019
    Assignees: Wisconsin Alumni Research Foundation, Stemina Biomarker Discovery, Inc.
    Inventors: Gabriela Gebrin Cezar, Alan M. Smith
  • Metabolic Biomarkers of Autism
    Publication number: 20170192019
    Abstract: This invention provides methods and biomarkers for diagnosing autism by identifying cellular metabolites differentially produced in autistic patient samples versus non-autistic controls. Methods for identifying a unique profile of metabolites present of secreted in brain tissue, cerebrospinal fluid, plasma, or biofluids of autistic samples are described herein. The individual metabolites or a pattern of secreted metabolites provide metabolic signatures of autism, which can be used to provide a diagnosis thereof.
    Type: Application
    Filed: December 7, 2016
    Publication date: July 6, 2017
    Inventors: Gabriela Gebrin Cezar, Alan M. Smith
  • Molecule biomarkers of autism
    Patent number: 9547013
    Abstract: This invention provides methods and biomarkers for diagnosing autism by identifying cellular metabolites differentially produced in autistic patient samples versus non-autistic controls. Methods for identifying a unique profile of metabolites present of secreted in brain tissue, cerebrospinal fluid, plasma, or biofluids of autistic samples are described herein. The individual metabolites or a pattern of secreted metabolites provide metabolic signatures of autism, which can be used to provide a diagnosis thereof.
    Type: Grant
    Filed: April 29, 2011
    Date of Patent: January 17, 2017
    Assignees: Wisconsin Alumni Research Foundation, Stemina Biomarker Discovery, Inc.
    Inventors: Gabriela Gebrin Cezar, Alan M. Smith
  • MOLECULE BIOMARKERS OF AUTISM
    Publication number: 20120190055
    Abstract: This invention provides methods and biomarkers for diagnosing autism by identifying cellular metabolites differentially produced in autistic patient samples versus non-autistic controls. Methods for identifying a unique profile of metabolites present of secreted in brain tissue, cerebrospinal fluid, plasma, or biofluids of autistic samples are described herein. The individual metabolites or a pattern of secreted metabolites provide metabolic signatures of autism, which can be used to provide a diagnosis thereof.
    Type: Application
    Filed: April 29, 2011
    Publication date: July 26, 2012
    Applicants: STEMINA BIOMARKER DISCOVERY, INC., WISCONSIN ALUMNI RESEARCH FOUNDATION
    Inventors: Gabriela Gebrin Cezar, Alan M. Smith